Login   |   Check Out   |   View Cart0 Items

 

Press Releases

Corporate News

2/6/2013

BIOLINE LAUNCHES ISOLATE II (DNA & RNA ISOLATION)

11/28/2012

SensiFAST™ GENOTYPING KIT EXCEED THE LIMIT

9/27/2010

MLS Successfully Manufacturers 2nd cGMP Production Campaign

8/31/2010

RSV M37 CLINICAL CHALLENGE VIRUS MANUFACTURED BY MLS

8/12/2010

MLS successfully manufactures norovirus Vlp Drug substances for Ligocyte

7/28/2010

MERIDIAN LIFE SCIENCE EXPANDS R&D AND CONTRACT MANUFACTURING FACILITIES IN MEMPHIS

7/20/2010

MERIDIAN BIOSCIENCE ACQUIRES LEADING MANUFACTURER AND DISTRIBUTOR OF MOLECULAR REAGENTS

5/19/2009

MLS Achieves Production Specification for the Australian Neonatal Rotavirus Vaccine

5/14/2009

MLS to Present at Bio 2009

1/23/2009

MLS Expands cGMP Facility

6/16/2008

MLS Completes Vybion Product Acquisition

5/13/2008

Meridian Signs Agreement to acquire Vybion Proteins

 

Product News

4/22/2013

New Infectious Disease Catalog

3/29/2013

Introducing Additional Fermentation Capabilities

2/27/2013

MAb to Calprotectin L1 Protein

2/4/2013

Immunoassay Blocking Agents - Update

1/4/2012

MAbs to CRP

9/27/2011

Varicella-Zoster Virus

8/31/2011

High Performance PCR Reagents

7/25/2011

MAbs to CA19-9

6/8/2011

MLS Offers Coenzymes, Enzymes & Substrates

4/27/2011

Campylobacter jejuni Products

3/21/2011

Dengue Product Offerings

2/25/2011

Bioline Launches SensiFast™ Real-Time PCR Kits

1/17/2011

MAbs to Prostate Specific Antigen (PSA) Pairs for Immunoassay

10/12/2010

Contract Manufacturers Bank on New Initiatives to Boost Capabilities

10/5/2010

MLS complete a 2nd clinical cGMP production lot RV3 rotavirus vaccine

9/13/2010

Reducing Errors in Immunoassay Testing - GEN Article

9/7/2010

In vivo and In vitro MAb Contract Manufacturing

8/4/2010

MLS Launches New MAbs to Chlamydia

7/12/2010

Purified Cytomegalovirus Antigen

5/6/2010

Performance Gains & Cost Savings w/TRU Block

4/28/2010

MAb ot Rotavirus, VP6

4/19/2010

MAbs to Rubella in Purified Form

3/29/2010

MAbs to RSV Nucleoprotein

2/23/2010

MLS Introduces Lyophilized M-IgG

1/26/2010

MAb to Cryptococcus neoformans

12/18/2009

TRU Block Effectively Blocks RF

11/11/2009

MAbs to Adenovirus Type 40, 41, and Both

9/21/2009

Pandemic Influenza Strain Antibodies & Peptides

9/3/2009

Protein Products in Yeast

7/29/2009

Blocking Agents - Part 2

5/19/2009

Swine Flu 2009 Update

5/11/2009

Blocking Agents Part 1

5/4/2009

Publication Cites use of MLS Toxoplasma gondii Antibody and Protein

4/14/2009

Researchers use MLS Purified Mouse Apo A1 as a standard

3/24/2009

High Performance Clones for Hormones

3/18/2009

Hormones and Steroids Product Line

3/10/2009

MLS Influenza Viruses Used to Test for Antibodies in Vaccine Delivery Study

2/25/2009

New MLS Infectious Disease Antigen Product Brochure

2/16/2009

TRU Block - Novel Active Blocker Released by MLS

1/26/2009

hCG Antigens and Antibodies

1/13/2009

Specification Sheets with Images

12/22/2008

Custom Antibody Production: In Vivo and In Vitro

12/11/2008

Publication Cites Use of HCV NS-5A and NS-4 MAbs

11/25/2008

Publication Cites MLS ApoB and A1AT Antibody use in HCV/VLDL Research

11/4/2008

FDA Publication Cites MLS Ab to Bioterrorism Agents

9/22/2008

TORCH Antigens

8/28/2008

Herpes Simplex Virus

8/6/2008

New Infectious Disease e-Catalog

7/26/2008

HBV and Apoptotic Caspase Activity

6/28/2008

Chicken Antibodies (Animal Immunoglobulins)

4/4/2008

Escherichia coli

3/13/2008

Hepatitis C

2/25/2008

MAb Production Brochure

2/6/2008

Bone/Calcium Metabolism

1/29/2008

Infectious Disease Focus (TB/HIV)

1/15/2008

Autoimmune Diseases

bioline
Copyright © 2013 Meridian Life Science,® Inc.